ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $4.23M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
11
Holding in Top 10
–
Calls
$1.76M
Puts
–
Top Buyers
| 1 | +$394K | |
| 2 | +$373K | |
| 3 | +$210K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$137K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$134K |
Top Sellers
| 1 | -$468K | |
| 2 | -$411K | |
| 3 | -$245K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$104K |
| 5 |
Morgan Stanley
New York
|
-$104K |